Revolution Medicines’ drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial.
Source: US Top News and Analysis
Related Posts
Meta must face youth addiction lawsuit by Massachusetts, court rules
The decision follows a landmark trial in which a jury found Meta and Google negligent…
Prediction markets will grow to $1 trillion by 2030, Bernstein estimates
The investment bank said volumes will reach an estimated $240 billion in 2026 and grow…
European stocks plunge after Trump vows to hit Iran ‘extremely hard’
Stocks listed in Europe fell on Thursday, as investors reacted to U.S. President Donald Trump’s…